SEC Form 4/A · accession 0001493152-26-036583
OKYO Pharma Ltd · OKYO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Gary S Jacob
Officer — CHIEF DEVELOPMENT OFFICER · Director
Period of report
Jul 21, 2026
Accepted (ET)
Aug 7, 2026 · 4:15 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001849296
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| COMMON STOCK | Jul 21, 2026 | P | 3,500 | $1.40 | A | 112,420 | D |
Table II — derivative securities
No Table II lines on this filing.
Remarks
This Form 4/A amends the Form 4 filed on July 23, 2026 solely to correct the transaction code associated with this open market purchase. No other reported transactions are affected by this amendment.